| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/CIRCULATIONAHA.105.544031 |
| P698 | PubMed publication ID | 16651474 |
| P50 | author | Vasilios Papademetriou | Q40602122 |
| Barry R. Davis | Q64684716 | ||
| David C Goff | Q96109271 | ||
| P2093 | author name string | Linda B Piller | |
| Richard Crow | |||
| Michael Proschan | |||
| Jeffrey A Cutler | |||
| Curt Furberg | |||
| Syed Mohiuddin | |||
| Frans Leenen | |||
| Allan Ellsworth | |||
| John Golden | |||
| Kay Dunn | |||
| Pedro Colon | |||
| Stanley Franklin | |||
| Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group | |||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart failure | Q181754 |
| P304 | page(s) | 2201-2210 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial | |
| P478 | volume | 113 |
| Q33576830 | ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses |
| Q35669321 | Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension |
| Q38615589 | Benefits and risks of antihypertensive medications in the elderly |
| Q37011769 | Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations |
| Q34581755 | Combination therapy with renin-angiotensin system blockers: will amlodipine replace hydrochlorothiazide? |
| Q91740206 | Compelling therapy of LVH: straight (and not-so-straight) inferences from evidence |
| Q38261197 | Current perspectives on systemic hypertension in heart failure with preserved ejection fraction |
| Q36482365 | Cystatin C concentration as a predictor of systolic and diastolic heart failure |
| Q80957351 | Diabetic cardiomyopathy |
| Q30451529 | Diabetic cardiovascular disease: getting to the heart of the matter |
| Q52654959 | Echocardiographic feature of diabetic cardiomyopathy: where are we now? |
| Q45813085 | Effect of cardiovascular drug classes on all-cause mortality among atrial fibrillation patients treated in primary care in Sweden: a cohort study |
| Q48852919 | Effects of an angiotensin 2 receptor blocker plus diuretic combination drug in chronic heart failure complicated by hypertension |
| Q61458207 | Effects of prescribed antihypertensives and other cardiovascular drugs on mortality in patients with atrial fibrillation and hypertension: a cohort study from Sweden |
| Q35819739 | Factors associated with 30-day readmission of patients with heart failure from a Japanese administrative database |
| Q24186647 | First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension |
| Q93336584 | First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension |
| Q81967929 | Funding a clinical trial: the perspective of a medicines funder |
| Q33964895 | Getting clinical trial results into practice: design, implementation, and process evaluation of the ALLHAT Dissemination Project |
| Q26801170 | Glycemia Lowering and Risk for Heart Failure: Recent Evidence from Studies of Dipeptidyl Peptidase Inhibition |
| Q49204428 | Heart Failure in Patients with Preserved Ejection Fraction: Questions Concerning Clinical Progression |
| Q37459609 | Heart failure in ALLHAT: did blood pressure medication at study entry influence outcome? |
| Q38022713 | Heart failure in hypertension: prevention and treatment |
| Q91873717 | Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction |
| Q98891712 | Indian guidelines on hypertension-IV (2019): need to differentiate thiazide-like diuretics |
| Q30377910 | Insulin Signaling and Heart Failure. |
| Q80450513 | JNC-7 guidelines: are they still relevant? |
| Q35553265 | Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). |
| Q93790631 | Minerva |
| Q89868482 | Mortality and Morbidity in HFrEF, HFmrEF, and HFpEF Patients with Diabetes in the Middle East |
| Q33965660 | Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex. |
| Q37603551 | Pre-clinical diastolic dysfunction |
| Q34437117 | Predictors of heart failure in patients with stable coronary artery disease: a PEACE study |
| Q64076693 | Prevention of Heart Failure in Hypertension-Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study |
| Q36200030 | Primary prevention of heart failure |
| Q37724505 | Review article: Diabetes mellitus and heart failure--an overview of epidemiology and management |
| Q36403208 | Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT]) |
| Q88711483 | The Bi-directional Impact of Two Chronic Illnesses: Heart Failure and Diabetes - A review of the Epidemiology and Outcomes |
| Q51034590 | The Effect of Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibitors on Cardiometabolic Profile; Beyond the Hypoglycaemic Action. |
| Q83717941 | The association of a simple blood pressure-independent parameter derived from ambulatory blood pressure variability with short-term mortality |
| Q37097887 | The under-representation of older people in clinical trials: barriers and potential solutions. |
| Q33964868 | Thiazide-type diuretics and beta-adrenergic blockers as first-line drug treatments for hypertension |
| Q36933054 | Treatment of hypertension among African Americans: the Jackson Heart Study |
| Q84889663 | [Special care requirements of elderly and old people: as reflected in the new Council of Experts Report] |
Search more.